24,476.69
+446.51
(+1.86%)
8,143.28
+145.99
(+1.83%)
4,858.87
+127.31
(+2.69%)
4,067.07
+30.48
(+0.755%)
4,900.20
+23.89
(+0.490%)
15,493.28
+94.55
(+0.614%)
63,950.0000
+719.9900
(1.139%)
26/02/2026 13:03
大行報告 | 滙控績後最新評級/目標價,生物股邊隻好?一表盡掌握
.三間大行績後看好滙控(00005),其中華泰看好166.07元
.瑞銀上調生物股,其中藥明康德(02359)目標價由138.4元上調至153.1元
.瑞銀下調科濟藥業(02171)及諾誠健華(09969)目標,分別看27元及21.1元
1069,,新聞,專題透視,reports